Diagnosis and management of poor neonatal adaptation syndrome in newborns exposed in utero to selective seretonin/norepinephrine reuptake inhibitors.
Koren
Gideon
G
The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, ON.
Finkelstein
Yaron
Y
The Motherisk Program, Division of Clinical Pharmacology and Toxicology, The Hospital for Sick Children, University of Toronto, Toronto, ON.
Matsui
Doreen
D
Department of Pediatrics, Univeristy of Western Ontario, London ON.
Berkovich
Matitiahu
M
Department of Pediatrics, Assaf Harofe Hospital, Tel Aviv University, Tel Aviv, Israel.
D003863:Depression / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D009357:Neonatal Abstinence Syndrome / Q000175:diagnosis* / Q000628:therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
D017367:Selective Serotonin Reuptake Inhibitors